Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Circumstances involved in unsupervised solid dose medication exposures among young children.

Agarwal M, Lovegrove MC, Geller RJ, et al. Circumstances involved in unsupervised solid dose medication exposures among young children. J Pediatr. 2020;219. doi:10.1016/j.jpeds.2019.12.027.

Save
Print
April 22, 2020
Agarwal M, Lovegrove MC, Geller RJ, et al. J Pediatr. 2020;219.
View more articles from the same authors.
Parents are advised to keep medications inaccessible to young children to avoid accidental ingestions. This study prospectively enrolled nearly 4,500 individuals calling poison control centers about unsupervised solid dose medication exposure in young children (ages 5 years and younger) to identify the types of containers from which young children accessed these medications. The majority of incidents (71.6%) involved children 2 years and younger. Incidents were equally divided among calls involving prescription-only medications, over-the-counter (OTC) projects requiring child-resistant packaging, and OTC projects not requiring such packaging. One-third of all incidents involved medication that had been removed from the original container; this was more likely in incidents involving prescription drugs compared to OTC drugs (adjusted odds ratio, 3.39; 95% CI, 2.87-4.00).  These findings suggest that unsupervised medication exposures in young children are just as often the result of adults removing medications from original packaging as the result of improper use or failure of child-resistant packaging.
Save
Print
Cite
Citation

Agarwal M, Lovegrove MC, Geller RJ, et al. Circumstances involved in unsupervised solid dose medication exposures among young children. J Pediatr. 2020;219. doi:10.1016/j.jpeds.2019.12.027.